NanoEcho AB (publ) (OSTO:NANECH) ROCE %: -127.47% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NanoEcho AB (publ) ROCE %?

NanoEcho AB (publ) OSTO:NANECH ROCE % is -127.47% as of Mar. 2026. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NanoEcho AB (publ)'s annualized ROCE % for the quarter that ended in Mar. 2026 was -127.47%.

NanoEcho AB (publ)  (OSTO:NANECH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NanoEcho AB (publ) ROCE % Related Terms

NanoEcho AB (publ) ROCE % Historical Data

* Premium members only.

The historical data trend for NanoEcho AB (publ)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoEcho AB (publ) ROCE % Chart

NanoEcho AB (publ) Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
-116.08 -87.78 -81.92 -88.30

NanoEcho AB (publ) Quarterly Data
Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -79.48 -79.41 -41.63 -91.45 -127.47

NanoEcho AB (publ) ROCE % Calculation

NanoEcho AB (publ)'s annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-14.66/( ( (33.256 - 14.782) + (18.416 - 3.684) )/ 2 )
=-14.66/( (18.474+14.732)/ 2 )
=-14.66/16.603
=-88.30 %

NanoEcho AB (publ)'s ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-20.396/( ( (18.416 - 3.684) + (21.775 - 4.505) )/ 2 )
=-20.396/( ( 14.732 + 17.27 )/ 2 )
=-20.396/16.001
=-127.47 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -127.47% mean?
NanoEcho AB (publ) (OSTO:NANECH) has a ROCE % of -127.47% as of Mar. 2026.
Is NanoEcho AB (publ)'s ROCE % too high?
NanoEcho AB (publ)'s current ROCE % is -127.47%.
How does NanoEcho AB (publ)'s ROCE % compare to VRTX and REGN?
NanoEcho AB (publ)'s ROCE % of -127.47% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. NanoEcho AB (publ)'s current ROCE % is -127.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoEcho AB (publ) stock overvalued right now?
NanoEcho AB (publ) (OSTO:NANECH) has a current ROCE % of -127.47%. The current ROCE % is -127.47%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For NanoEcho AB (publ) (OSTO:NANECH), the current ROCE % is -127.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NanoEcho AB (publ) Business Description

Other Exchanges XT4:Germany
Address Scheelevagen 19, Lund, SWE, 223 63
NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.